We are open with limited hours and staff.
Price range: $160.00 through $1,047.00
Pregabalin 225mg is a prescription medication containing pregabalin, an anticonvulsant used for several nerve-related conditions. The 225mg capsule is one of the strengths listed in current FDA prescribing information. Depending on the medical indication, pregabalin may be prescribed for certain types of neuropathic pain, fibromyalgia, spinal cord injury-related nerve pain, and as adjunctive treatment for partial-onset seizures.
Pregabalin affects signaling within the nervous system and may help manage specific forms of nerve pain or support seizure control when appropriately prescribed. For example, approved uses include diabetic peripheral neuropathy, postherpetic neuralgia, and neuropathic pain associated with spinal cord injury. It is also indicated for fibromyalgia and certain seizure disorders.
However, the appropriate strength varies from person to person. Treatment decisions can depend on the condition being treated, response to therapy, and kidney function. Therefore, Pregabalin 225mg should be used only according to directions from a qualified healthcare professional. The FDA notes that dosage adjustments may be needed for adults with reduced renal function.
Pregabalin can cause dizziness and sleepiness, which may affect concentration, coordination, driving, or the operation of machinery. Other commonly reported effects include dry mouth, blurred vision, swelling, weight gain, and difficulty with concentration or attention.
Additionally, serious hypersensitivity reactions can occur. Swelling of the face, mouth, throat, or neck may indicate angioedema and can cause breathing difficulties. Consequently, urgent medical attention is appropriate when severe allergic symptoms or breathing problems develop.
Furthermore, respiratory depression may occur, particularly when pregabalin is combined with central nervous system depressants or used by people with certain respiratory risk factors. For this reason, healthcare professionals should be informed about all prescription medicines, over-the-counter products, and other substances being used.
For responsible use, follow the prescribed treatment plan carefully and do not change the strength or schedule without professional guidance. Pregabalin should not be stopped suddenly. Instead, current FDA labeling recommends gradual tapering over at least one week when treatment is discontinued.
Moreover, prescription medication should be stored securely and never shared with another person. Patients should also report concerning reactions, unusual symptoms, or significant changes in their condition to their healthcare professional.
Pregabalin 225mg is therefore one available prescription strength rather than a universal dose. Appropriate medical evaluation can help determine whether pregabalin is suitable and which treatment approach is appropriate for an individual patient.
